Medline, Inc. (MDLN)
35.46
-0.10
(-0.27%)
USD |
NASDAQ |
Oct 07, 16:00
34.95
-0.50
(-1.42%)
After-Hours: 18:41
Medline Enterprise Value : 48.64B for Oct. 6, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 06, 2026 | 48.64B |
| October 05, 2026 | 48.86B |
| October 02, 2026 | 48.70B |
| October 01, 2026 | 48.11B |
| September 30, 2026 | 47.90B |
| September 29, 2026 | 48.14B |
| September 28, 2026 | 48.22B |
| September 25, 2026 | 47.90B |
| September 24, 2026 | 47.86B |
| September 23, 2026 | 47.55B |
| September 22, 2026 | 47.66B |
| September 21, 2026 | 45.49B |
| September 18, 2026 | 45.21B |
| September 17, 2026 | 45.64B |
| September 16, 2026 | 46.40B |
| September 15, 2026 | 45.63B |
| September 14, 2026 | 46.05B |
| September 11, 2026 | 45.99B |
| September 10, 2026 | 45.87B |
| September 09, 2026 | 47.33B |
| September 08, 2026 | 47.89B |
| September 04, 2026 | 49.56B |
| September 03, 2026 | 49.56B |
| September 02, 2026 | 49.30B |
| September 01, 2026 | 48.26B |
| Date | Value |
|---|---|
| August 31, 2026 | 48.19B |
| August 28, 2026 | 48.41B |
| August 27, 2026 | 47.85B |
| August 26, 2026 | 47.79B |
| August 25, 2026 | 48.72B |
| August 24, 2026 | 47.90B |
| August 21, 2026 | 47.51B |
| August 20, 2026 | 46.04B |
| August 19, 2026 | 47.21B |
| August 18, 2026 | 47.39B |
| August 17, 2026 | 48.06B |
| August 14, 2026 | 48.81B |
| August 13, 2026 | 48.67B |
| August 12, 2026 | 48.60B |
| August 11, 2026 | 48.20B |
| August 10, 2026 | 47.12B |
| August 07, 2026 | 48.36B |
| August 06, 2026 | 47.73B |
| August 05, 2026 | 49.62B |
| August 04, 2026 | 54.34B |
| August 03, 2026 | 52.96B |
| July 31, 2026 | 51.91B |
| July 30, 2026 | 51.77B |
| July 29, 2026 | 52.62B |
| July 28, 2026 | 52.99B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Insulet Corp. | 9.757B |
| Abbott Laboratories | 197.51B |
| AngioDynamics, Inc. | 558.41M |
| Alphatec Holdings, Inc. | 2.118B |
| AtriCure, Inc. | 2.637B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 139.00M |
| Revenue (Quarterly) | 7.685B |
| Total Expenses (Quarterly) | 7.625B |
| EPS Diluted (Quarterly) | 0.0697 |
| Gross Profit Margin (Quarterly) | 26.52% |
| Profit Margin (Quarterly) | 1.81% |
| Earnings Yield | 2.41% |
| Operating Earnings Yield | 6.66% |
| Normalized Earnings Yield | 3.794 |